GNH USA

Europe — EMA

Olmesartan Medoxomil/Amlodipine Accord (Olmesartan Medoxomil, Amlodipine)

GNH USA supplies Olmesartan Medoxomil/Amlodipine Accord (Olmesartan), an ARB/CCB combo for hypertension. Request a quote for global supply.

Olmesartan Medoxomil, Amlodipine

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Amlodipine?

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Amlodipine Accord, is an angiotensin II receptor blocker presented as a fixed‑dose combination for oral use. It treats hypertension, often in adults who require more than one medication to reach blood‑pressure goals.

GNH USA supplies Olmesartan Medoxomil/Amlodipine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Amlodipine used for?

Olmesartan Medoxil/Amlodipine Accord is used in cardiovascular therapy, primarily targeting high blood pressure and related conditions. - Hypertension: Lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertensive heart disease: Improves cardiac workload by controlling blood pressure. - Chronic kidney disease with hypertension: Slows progression of renal impairment by maintaining target blood‑pressure levels.

What are the side effects of Olmesartan Medoxomil, Amlodipine?

Adverse reactions may occur with any antihypertensive combination and should be monitored.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Dizziness or light‑headedness: especially after standing. - Flushing: transient warmth sensation. - Fatigue: general tiredness. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Angio‑edema: rapid swelling of face, lips or throat. - Severe hypotension: symptomatic low blood pressure. - Hepatic dysfunction: elevated liver enzymes. - Acute kidney injury: sudden decline in renal function. - Myocardial infarction: rare but reported in vulnerable patients. - Hyperkalemia: elevated potassium levels.

What precautions apply to Olmesartan Medoxomil, Amlodipine?

When prescribing Olmesartan Medoxil/Amlodipine Accord, clinicians should consider several safety aspects. - Renal impairment: adjust monitoring and avoid in severe failure. - Hepatic disease: use with caution; monitor liver function. - Electrolyte imbalance: watch potassium levels, especially with diuretics. - Pregnancy: contraindicated in the second and third trimesters. - Elderly patients: start low and titrate slowly to reduce orthostatic effects. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Olmesartan Medoxomil, Amlodipine interact with?

Olmesartan Medoxil/Amlodipine Accord can interact with several medicines, requiring clinical awareness.

Major Interactions (Avoid): - Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, other ARBs): increased risk of renal dysfunction and hyperkalaemia. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): raise amlodipine levels, risking hypotension.

Moderate Interactions (Monitor Closely): - Diuretics: additive blood‑pressure lowering effect; monitor volume status. - NSAIDs: may blunt antihypertensive response and affect renal function. - Lithium: possible increase in serum lithium concentrations. - Simvastatin: amlodipine can increase statin exposure, raising myopathy risk. - Alcohol: may enhance dizziness and hypotensive effects.

Frequently asked questions

What is Olmesartan Medoxomil/Amlodipine Accord used for?+
Olmesartan Medoxomil/Amlodipine Accord is a fixed‑dose oral tablet that combines an angiotensin‑II receptor blocker with a calcium‑channel blocker. It is prescribed to lower high blood pressure in adults, especially when a single agent does not achieve target readings.
How does Olmesartan medoxil work in the body?+
Olmesartan medoxil blocks the AT1 receptor for angiotensin II, preventing vasoconstriction and aldosterone‑driven fluid retention. Amlodipine relaxes vascular smooth muscle by inhibiting calcium entry, producing arterial dilation. Together they reduce peripheral resistance and lower blood‑pressure levels.
What is the usual dose of Olmesartan Medoxomil/Amlodipine Accord?+
The specific dose of Olmesartan Medoxomil/Amlodipine Accord is determined by the prescribing clinician based on the patient’s blood‑pressure goals, renal function, age and concomitant therapies. Dosage adjustments are made individually and are not standardized across all patients.
Is Olmesartan Medoxomil/Amlodipine Accord safe during pregnancy or breastfeeding?+
Olmesartan medoxil is contraindicated in the second and third trimesters of pregnancy because of fetal toxicity risk, and it should be avoided unless clearly needed. Safety data for amlodipine during breastfeeding are limited; the combination should only be used if the potential benefit outweighs any possible risk to the infant.
How do I order Olmesartan Medoxomil/Amlodipine Accord from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, indicating the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does this combination compare with other antihypertensive options?+
Compared with monotherapy, the Olmesartan‑amlodipine combo offers additive blood‑pressure reduction, often achieving target levels with a single tablet. It may be preferred over separate pills for adherence, and it provides a broader mechanism of action than either an ARB or a calcium‑channel blocker alone.
What are the recommended storage conditions for Olmesartan Medoxomil/Amlodipine Accord?+
Store the tablets at ambient temperature, below 25 °C, in the original container. Protect them from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf‑life.
How is Olmesartan Medoxomil/Amlodipine Accord administered?+
The medication is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a glass of water and follow the prescribing clinician’s instructions regarding timing and any dose adjustments.
What are the most serious risks associated with this medication?+
Serious adverse events include angio‑edema, severe hypotension, acute kidney injury, hepatic dysfunction and hyper‑kalaemia. Patients should seek immediate medical attention if they experience rapid swelling of the face or throat, fainting, marked dizziness or sudden loss of kidney function.
Who should not take Olmesartan Medoxomil/Amlodipine Accord?+
The combination should be avoided in patients with known hypersensitivity to either component, in pregnant women beyond the first trimester, and in individuals with severe renal or hepatic impairment unless closely supervised by a specialist.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Olmesartan Medoxomil, Amlodipine
Route
Oral Use
Manufacturer
Accord Healthcare B.V.
Origin
EU

Related products

Albis

Albis

Olmesartan Medoxomil, Amlodipine

Laboratorios Alter, S.A.
EU
Almacor Duo

Almacor Duo

Olmesartan Medoxomil, Amlodipine

Antibiotice Sa
EU
Alsamod

Alsamod

Olmesartan Medoxomil, Amlodipine

Krka, D.D., Novo Mesto
EU
Amelior

Amelior

Olmesartan Medoxomil, Amlodipine

Menarini International Operations Luxembourg S.A.
EU